UTERINE ARTERY DOPPLER IN PREECLAMPSIA: CORRELATION WITH DISEASE SEVERITY AND PREGNANCY OUTCOME
Main Article Content
Keywords
preeclampsia; uterine artery Doppler; pulsatility index; resistance index; notching; fetal growth restriction; pregnancy outcome
Abstract
Preeclampsia is a multisystem hypertensive disorder of pregnancy associated with abnormal placentation and impaired uteroplacental perfusion. Uterine artery Doppler provides a non-invasive assessment of uteroplacental vascular resistance and may help identify pregnancies at increased risk of severe disease and adverse outcome.
Aim: To evaluate uterine artery Doppler indices in women with preeclampsia and determine their correlation with disease severity and pregnancy outcome.
Methods: One hundred pregnant women diagnosed with preeclampsia after 20 weeks of gestation were evaluated prospectively. Bilateral uterine artery Doppler was performed using pulsed-wave Doppler. Pulsatility index (PI), resistance index (RI), systolic/diastolic ratio and persistent early diastolic notching were recorded. Maternal disease severity, gestational age at delivery, mode of delivery, birth weight, NICU admission and adverse perinatal outcome were documented.
Results: The mean gestational age at Doppler assessment was 32.8 ± 3.1 weeks. Severe preeclampsia was present in 38% of women. Mean bilateral uterine artery PI was 1.48 ± 0.36 and RI was 0.69 ± 0.09. Mean PI was higher in severe than non-severe preeclampsia (1.76 ± 0.31 vs 1.31 ± 0.27). Persistent bilateral notching was present in 34%. Higher PI and bilateral notching were associated with earlier delivery, lower birth weight and increased NICU admission.
Conclusion: Elevated uterine artery Doppler resistance, particularly increased PI and persistent bilateral notching, was associated with greater disease severity and adverse pregnancy outcomes in this cohort. Uterine artery Doppler may provide useful complementary information for risk stratification when interpreted alongside clinical and biochemical findings.
References
2. International Society for the Study of Hypertension in Pregnancy. The 2021 ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2001;27:148–169.
3. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30 Suppl A:S32–S37.
4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594.
5. Burton GJ, Fowden AL. The placenta and developmental programming: balancing fetal demands with maternal resources. Placenta. 2002;33 Suppl:S23–S27.
6. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2010;124:1094–1112.
7. Papageorghiou AT, Yu CKH, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia by uterine artery Doppler at 23 weeks. Ultrasound Obstet Gynecol. 2005;25:221–230.
8. Gomez O, Figueras F, Martinez JM, et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol. 2006;28:802–808.
9. Cnossen JS, Morris RK, Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction. BMJ. 2008;336:752–756.
10. Scazzocchio E, Figueras F. Contemporary prediction of preeclampsia. Curr Opin Obstet Gynecol. 2011;23:65–71.
11. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by uterine artery Doppler. Ultrasound Obstet Gynecol. 2000;16:192–196.
12. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11–13 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30:742–749.
13. Gomez O, Figueras F, Fernandez S, et al. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32:128–132.
14. Campbell S, Black RS, Lees C, Armstrong V, Peacock JL. Doppler ultrasound of the maternal uterine arteries: a marker of impaired placental perfusion and adverse pregnancy outcome. Br J Obstet Gynaecol. 1993;100:633–637.
15. Papageorghiou AT, Yu CKH, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations. Ultrasound Obstet Gynecol. 2002;20:1–4.
16. Poon LC, Shennan A, Hyett JA, et al. FIGO initiative on pre-eclampsia: first-trimester screening and prevention. Int J Gynaecol Obstet. 2014;145 Suppl 1:1–33.
17. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2012;377:613–622.
18. O'Gorman N, Wright D, Poon LC, et al. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks. Ultrasound Obstet Gynecol. 2011;49:756–760.
19. Sotiriadis A, Hernandez-Andrade E, da Silva Costa F, et al. ISUOG Practice Guidelines: role of ultrasound in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2012;59:857–867.
20. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004;11:342–352.

